Effect of local anti-VEGF antibody treatment on tumor microvessel permeability

Microvascular Research

Volumn 57, Issue 3, 1999, Pages 357-362

  Lichtenbeld, Hera C ^a   Ferarra, Napoleone ^b   Jain, Rakesh K ^a   Munn, Lance L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GENENTECH INC   (United States)

Author keywords

Anti VEGF antibody; Permeability; Single vessel perfusion; Tumors; Vascular endothelial growth factor (VEGF)

Indexed keywords

NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR VASCULARIZATION;

ANIMALIA;

EID: 0032815368     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1998.2140     Document Type: Article

References (28)

1. Asano M., Yukita A., Matsumoto S., Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to vascular endothelial growth factor/vascular permeability factor. Cancer Res. 55:1995;5226-5231.
2. Brem H., Piantadosi S., Burger P. C., Walker M., Selker R., Vick N., Langer R. Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 345:1995;1008-1012.
3. Brown L. F., Detmar M., Claffey K., Nagy J. A., Feng D., Dvorak A. M., Dvorak H. F. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. Regulation of Angiogenesis. 1997;Birkhauser Verlag, Basel.
4. Brown L. F., Detmar M., Claffey K., Nagy J. A., Feng D., Dvorak A. M., Dvorak H. F. VPF/VEGF: A multifunctional angiogenic cytokine. Goldberg I. D., Rosen E. M. Regulators of Angiogenesis. 1998;233-269 Birkhauser Verlag, Basel.
5. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawlings J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
6. Detmar M., Brown L., Schon M., Elicker B., Richard L., Velasco P., Fukumura D., Monsky W., Claffey K., Jain R. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 3:1998;1-6.
7. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1995a;1029-1039.
8. Dvorak H. F., Detmar M., Claffey K. P., Nagy J. A., Vandewater L., Senger D. R. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107:1995b;233-235.
9. Ergun S., Kilic N., Fiedler W., Mukhopadhyay A. K. Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol. Cell. Endocrinol. 131:1997;9-20.
10. Ferarra N. Heterozygotes embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
11. Ferarra N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25.
12. Ferrara N., Chen H., Davis-Smyth T., Gerber H., Nguyen T., Peers D., Chisholm V., Hillan K., Schwall R. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4:1998;336-340.
13. Fukumura D., Xavier R., Sugiura T., Chen Y., Parks E., Lu N., Selig M., Nielsen G., Taksir T., Jain R., Seed B. Tumor induction of VEGF promotor activity in stromal cells. Cell. 94:1998;715-725.
14. Gerlowski L., Jain R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31:1986;288-305.
15. Hobbs S., Monsky W., Yuan F., Roberts G., Griffiths L., Torchillin V., Jain R. K. Regulation of transport pathways in tumor vessels: Role of tumor type and host microenvironment. Proc. Natl. Acad. Sci. USA. 95:1998;4607-4612.
16. Jain R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6:1987;559-593.
17. Jain R. K., Safabakhsh N., Sckell A., Chen Y., Jiang P., Benjamin L., Yuan F., Keshet E. Endothelial cell death, angiogenesis and microvascular function following castration in an androgen-dependent tumor: Role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA. 95:1998a.
18. Jain, R. K. Yuan, F. Detmar, M. Brown, L. Dvorak, H. 1998b, VPF/VEGF is necessary but not sufficient for tumor vascular hyperpermeability.
19. Koole L., Kruft M. A., Aldenhoff Y., Van 't Oost N., Van Kroonenburgh M., Van der Veen F. Sustained local drug delivery from a radiopaque implanted reservoir. Nat. Biotechnol. 16:1998;172-176.
20. Leunig M., Yuan F., Menger M. D., Boucher Y., Goetz A. E., Messmer K., Jain R. K. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 52:1992;6553-6560.
21. Lichtenbeld H. C., Yuan F., Michel C. C., Jain R. K. Perfusion of single tumor microvessels: Application to vascular permeability measurement. Microcirculation. 3:1996;349-357.
22. Melnyk O., Shuman M. A., Kim K. J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56:1996;921-924.
23. O'Reilly M. S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W. S., Flynn E., Birkhead J., Olsen B., Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
24. Yamamoto S., Konishi I., Tsuruta Y., Nanbu K., Mandai M., Kuroda H., Matsushita K., Hamid A. A., Yura Y., Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol. Endocrinol. 11:1997;371-381.
25. Yuan F., Chen Y., Dellian M., Safabakhsh N., Ferrara N., Jain R. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA. 93:1996;14765-14770.
26. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D., Torchillin V., Jain R. Vascular permeability in a human tumor xenograft: Molecular size and dependence and cutoff size. Cancer Res. 55:1995;3752-3756.
27. Yuan F., Leunig M., Berk D., Jain R. K. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc. Res. 45:1993;269-289.
28. Yuan F., Salehi H., Boucher Y., Vasthare U. S., Tuma R. F., Jain R. K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54:1994;4564-4568.